Propanc Biopharma, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2021 | $950.2K | $-3.0M | $14.4K |
| Jun 2021 | $624.6K | $-3.1M | $2.3K |
| Sep 2021 | $584.6K | $-2.3M | $45.8K |
| Dec 2021 | $972.7K | $-2.9M | $73.6K |
| Mar 2022 | $1.1M | $-2.9M | $133.9K |
| Jun 2022 | $926.4K | $-3.0M | $4.1K |
| Sep 2022 | $913.6K | $-2.8M | $19.4K |
| Dec 2022 | — | $-2.9M | $24.5K |
| Mar 2023 | $519.7K | $-2.9M | $93.2K |
| Jun 2023 | $390.5K | $-3.1M | — |
| Sep 2023 | $397.4K | $-3.0M | — |
| Dec 2023 | $687.7K | $-3.6M | — |
| Mar 2024 | $583.0K | $-3.7M | — |
| Jun 2024 | $399.3K | $-3.8M | — |
| Sep 2024 | $381.8K | $-4.1M | — |
| Dec 2024 | $409.8K | $-4.2M | — |
| Mar 2025 | $438.6K | $18.1M | — |
| Jun 2025 | $537.9K | $13.9M | — |
| Sep 2025 | $107.0K | $14.4M | — |
| Dec 2025 | $55.0K | $10.5M | — |